; (B) employees of the Substance Abuse and Mental Health Service Administration; and (C) other stakeholders with expert knowledge of the opioid epidemic, drug treatment, and community addiction services, which may include law enforcement and public health entities. (2) Duties The review panel established under paragraph (1) shall review and evaluate applications for grants and cooperative agreements under this section, and make recommendations for the awarding of such grants and agreements to the Attorney General. (i) Publication of criteria in Federal Register Not later than 90 days after the date of the enactment of this Act, and in consultation with the review panel established under subsection (g), the Attorney General shall publish in the Federal Register the application process and criteria for grants and cooperative agreements under this section. (j) Authorization of appropriations There is authorized to be appropriated $50,000,000 to carry out this section for each of fiscal years 2019 through 2022. (k) Definitions In this section: (1) The term medication-assisted treatment means the use of drugs or combinations of drugs that have, under the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act, been approved for use in maintenance or detoxification treatment, in combination with counseling and behavioral therapies, to provide a comprehensive approach to the treatment of substance use disorders. (2) The term psychosocial means the interrelation of social factors and individual thought and behavior.